Seccia M, Albano E, Maggi E, Bellomo G
Department of Medical Sciences, University of Torino, Novara, Italy.
Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):134-40. doi: 10.1161/01.atv.17.1.134.
Oxidatively modified LDLs are antigenic and elicit the generation of autoantibodies often detected in plasma and within plaques of atherosclerotic patients. Although Cu(2+)-oxidized LDL and malondialdehyde (MDA)-modified LDL are usually used as antigens in immunoassays, other, still unrecognized epitopes may be formed in vivo during LDL oxidation and may induce antibody production. Antibodies recognizing LDL oxidatively modified by Cu2+, 2,2'-azobis-(2-amidino propane) hydrochloride (AAPH), and the combination of horseradish peroxidase and H2O2 (HRP) were detected in serum of a group of 90 unselected patients. HRP-oxidized LDL was the antigen that revealed the highest IgG titers, although the extent of LDL oxidation (evaluated as conjugated diene formation, loss of tryptophan fluorescence, production of fluorescent aldehydic adducts, and change in electrophoretic mobility) was comparable to that obtained with Cu2+ and AAPH. There was a highly statistically significant correlation between the IgG titers detected using Cu(2+)- and AAPH-oxidized LDLs as antigens, but no correlation was found between the IgG titers revealed by HRP and Cu2+ or AAPH. In addition, the antibody titers against MDA-modified LDL exhibited a significant correlation with those against Cu(2+)- or AAPH-oxidized LDL but did not correlate with those against HRP-oxidized LDL. Finally, immunocompetition experiments revealed that IgG recognizing HRP-oxidized LDL did not cross-react with Cu(2+)-oxidized LDL and vice versa. The possibility that lipid peroxidation-independent modifications could play a role in HRP-induced formation of antigenic epitopes in LDL was supported by two lines of evidence. First, in probucol-enriched LDL, despite the complete inhibition of lipid peroxidation, HRP, but not Cu2+ and AAPH, was still able to generate epitopes that were recognized by the same sera reacting with HRP-oxidized native (not probucol-enriched) LDL. In addition, the presence of autoantibodies against Cu(2+)- and AAPH-oxidized LDLs was negatively correlated with serum alpha-tocopherol concentration, whereas the titers against HRP-oxidized LDL did not exhibit any statistically relevant correlation with alpha-tocopherol levels. Together, these findings indicate that peroxidase(s)-dependent mechanisms can trigger peculiar lipid peroxidation-independent modifications of LDL in vivo.
氧化修饰的低密度脂蛋白具有抗原性,可引发自身抗体的产生,这些自身抗体常在动脉粥样硬化患者的血浆和斑块中被检测到。尽管铜(Cu²⁺)氧化的低密度脂蛋白和丙二醛(MDA)修饰的低密度脂蛋白通常在免疫测定中用作抗原,但在低密度脂蛋白氧化过程中,体内可能会形成其他尚未被识别的表位,并可能诱导抗体产生。在一组90名未经挑选的患者血清中检测到了识别被Cu²⁺、2,2'-偶氮双(2-脒基丙烷)盐酸盐(AAPH)以及辣根过氧化物酶和过氧化氢(HRP)组合氧化的低密度脂蛋白的抗体。HRP氧化的低密度脂蛋白是显示出最高IgG滴度的抗原,尽管低密度脂蛋白的氧化程度(通过共轭二烯形成、色氨酸荧光损失、荧光醛加合物的产生以及电泳迁移率的变化来评估)与用Cu²⁺和AAPH获得的程度相当。使用Cu²⁺和AAPH氧化的低密度脂蛋白作为抗原检测到的IgG滴度之间存在高度统计学显著的相关性,但HRP和Cu²⁺或AAPH显示的IgG滴度之间未发现相关性。此外,针对MDA修饰的低密度脂蛋白的抗体滴度与针对Cu²⁺或AAPH氧化的低密度脂蛋白的抗体滴度呈现出显著相关性,但与针对HRP氧化的低密度脂蛋白的抗体滴度不相关。最后,免疫竞争实验表明,识别HRP氧化的低密度脂蛋白的IgG与Cu²⁺氧化的低密度脂蛋白不发生交叉反应,反之亦然。脂质过氧化非依赖性修饰可能在HRP诱导的低密度脂蛋白抗原表位形成中起作用这一可能性得到了两方面证据的支持。首先,在富含普罗布考的低密度脂蛋白中,尽管脂质过氧化被完全抑制,但HRP仍能产生被与HRP氧化的天然(而非富含普罗布考的)低密度脂蛋白反应的相同血清所识别的表位,而Cu²⁺和AAPH则不能。此外,针对Cu²⁺和AAPH氧化的低密度脂蛋白的自身抗体的存在与血清α-生育酚浓度呈负相关,而针对HRP氧化的低密度脂蛋白的滴度与α-生育酚水平未显示出任何统计学上相关的相关性。总之,这些发现表明,依赖过氧化物酶的机制可在体内引发低密度脂蛋白特殊的脂质过氧化非依赖性修饰。